Logo Soluventis

Advancing Oligonucleotide Therapeutics

MANAGEMENT

Edvin N. Munk

Edvin N. Munk
- President and acting CEO -

Business executive with 20+ years experience in the life sciences and diagnostics industry. Held multiple global management positions at Sequenom, Inc. and Agena, Inc.. Currently serving as Vice President at Global Source Ventures to identify promising investment opportunities in Europe for innovative therapeutics and diagnostics.

Prof. Dr. Sören Schneider

Prof. Dr. Sören Schreiber
- Chief Scientific Officer and Founder -

Physician and professor of physiology. Head of numerous successful international research projects. Led several R&D cooperations with large pharmaceutical partners. Two decades of experiences with Nanocarrier technologies and inventor of the Soluventis platform. Founder of the company.

Dr. Désirée Garten

Dr. Désirée Garten
- Vice President Research & Development and Founder -

Physician with oncological experience, worked several years as postdoctoral research fellow. Together with Prof. Schreiber she advanced the Nanocarrier and worked on the development of new clinical target candidates for Nanocarrier-based molecular therapy. Founder of the company.

Michelle Zaniboni

Michelle Zaniboni
- Vice President Finance -

Financial professional serving as Vice President of Global Source Ventures LLC. Michelle's focus is financial operations of portfolio companies including fund raising, accounting, treasury, budgeting, financial planning and executional support. Prior to GSV, Michelle was a Research Associate at an international brokerage firm.